Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Persistence of Monotypic Plasma Cells after Chemoimmunotherapy in Patients with Waldenström Macroglobulinemia: A Matter of Time?

Marzia Varettoni, Emilia Cappello, Emanuela Boveri, Virginia Valeria Ferretti, Silvia Zibellini, Gianmarco Favrin, Chiara Varraso, Marco Lucioni, Cristina Picone, Giulia Vittoria Facchetti, Giovanni O. Palladini, Marco Paulli, Luca Arcaini

Blood (2024) 144 (Supplement 1): 4400.

https://doi.org/10.1182/blood-2024-207850

Published: 2024

Journal Articles

Prospective Evaluation of Minimal Residual Disease in Waldenström Macroglobulinemia across Different Tissues and Treatments: Results of the “BIO-WM” Trial of the Fondazione Italiana Linfomi (FIL)

Blood (2023) 142 (Supplement 1): 1621.

https://doi.org/10.1182/blood-2023-181731

Published: 2023

Journal Articles

Molecular Characterization of Diffuse Large B-Cell Lymphoma Associated to Hepatitis C Virus Infection

Blood (2021) 138 (Supplement 1): 2402.

https://doi.org/10.1182/blood-2021-152636

Published: 2021

Journal Articles

Relationship between clone metrics and clinical outcome in clonal cytopenia

Blood (2021) 138 (11): 965–976.

https://doi.org/10.1182/blood.2021011323

Published: 2021

Includes: Supplemental data

Journal Articles

Characterization of B-Cell and Plasma Cell Compartment By Eight-Color Multiparameter Flow Cytometry in Patients with Waldenstrom Macroglobulinemia Prospectively Enrolled in the Fondazione Italiana Linfomi (FIL) BIO-WM Trial

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-137119

Published: 2020

Journal Articles

Targeted Next Generation Sequencing Reveals Molecular Heterogeneity in Non-CLL Clonal B-Cell Lymphocytosis

Irene Defrancesco, Silvia Zibellini, Emanuela Boveri, Marco Frigeni, Virginia Valeria Ferretti, Ettore Rizzo, Francesca Capuano, Arturo Bonometti, Chiara Candido, Sara Rattotti, Elena Flospergher, Fabio Bergamini, Caterina Zerbi, Marco Paulli, Marzia Varettoni, Luca Arcaini

Blood (2019) 134 (Supplement_1): 1502.

https://doi.org/10.1182/blood-2019-130233

Published: 2019

Journal Articles

JAK inhibitors and risk of B-cell lymphomas

Elisa Rumi, Silvia Zibellini

Blood (2019) 133 (21): 2251–2253.

https://doi.org/10.1182/blood-2019-03-900951

Published: 2019

Journal Articles

Prevalence of Clonal Hematopoiesis and Mutation Patterns in Unexplained Anemia of Community-Dwelling Elderly Individuals: A Case-Control Study

Luca Malcovati, MD, Anna Gallì, Cinzia F Sala, Ettore Rizzo, Elisabetta Molteni, Silvia Zibellini, Eulalia Catamo, Erica Travaglino, Silvia Catricalà, Chiara Elena, Gabriele Todisco, ELISA Bono, MD, Antonio Bianchessi, Virginia Valeria Ferretti, Paolo Gasparini, Clara Camaschella, MD, Daniela Toniolo, Mario Cazzola, MD

Blood (2017) 130 (Supplement 1): 1684.

https://doi.org/10.1182/blood.V130.Suppl_1.1684.1684

Published: 2017

Journal Articles

Lymphoplasmacytic Lymphoma Not Associated with an IgM Monoclonal Paraprotein Has Distinctive Clinical and Biological Features and a Similar Outcome As Compared with Waldenstrom's Macroglobulinemia: Multicentric Study of the Rete Ematologica Lombarda

Blood (2017) 130 (Supplement 1): 4045.

https://doi.org/10.1182/blood.V130.Suppl_1.4045.4045

Published: 2017

Journal Articles

Clinical significance of somatic mutation in unexplained blood cytopenia

Blood (2017) 129 (25): 3371–3378.

https://doi.org/10.1182/blood-2017-01-763425

Published: 2017

Includes: Supplemental data

Journal Articles

Targeted Next Generation Sequencing Identifies Novel Genetic Mutations in Patients with Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma or IgM-Monoclonal Gammopathies of Undetermined Significance

Marzia Varettoni, Silvia Zibellini, Ettore Rizzo, Luca Malcovati, MD, Virginia Valeria Ferretti, Matteo Giovanni Della Porta, Anna Gallì, Luca Arcaini, Irene Defrancesco, Mario Cazzola

Blood (2016) 128 (22): 2928.

https://doi.org/10.1182/blood.V128.22.2928.2928

Published: 2016

Journal Articles

Somatic Mutations Are Frequently Detected in Chronic Myeloid Leukemia in Chronic Phase and Do Not Affect Response to Tyrosine-Kinase Inhibitors

Chiara Elena, MD, Anna Gallì, Antonio Bianchessi, Virginia Valeria Ferretti, PhD, Silvia Zibellini, Silvia Catricalà, Celeste Calvello, Barbara Rocca, Paolo Bernasconi, MD, Ettore Rizzo, Elisabetta Molteni, Luca Malcovati, MD, Matteo Giovanni Della Porta, Ester Maria Orlandi, MD, Mario Cazzola, MD

Blood (2016) 128 (22): 1117.

https://doi.org/10.1182/blood.V128.22.1117.1117

Published: 2016

Journal Articles

Driver Somatic Mutations and Transplantation Decision Making in Patients with Myelodysplastic Syndrome

Blood (2016) 128 (22): 53.

https://doi.org/10.1182/blood.V128.22.53.53

Published: 2016

Journal Articles

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia

Blood (2016) 128 (10): 1408–1417.

https://doi.org/10.1182/blood-2016-05-714030

Published: 2016

Includes: Supplemental data

Journal Articles

Efficacy and Toxicity of Nucleoside Analogs in Patients with Hairy Cell Leukemia Treated Outside Clinical Trials

Maria Luisa Guerrera, MD, Marzia Varettoni, MD, Alessandra Tedeschi, MD, Anna Maria Frustaci, MD, Virginia Valeria Ferretti, PhD, Luca Arcaini, Prof, Paola Picardi, MD, Silvia Zibellini, Sara Rattotti, MD, Roberto Cairoli, MD, Mario Cazzola, MD

Blood (2015) 126 (23): 5084.

https://doi.org/10.1182/blood.V126.23.5084.5084

Published: 2015

Journal Articles

Somatic Mutations of ASXL1 , RUNX1 and SETBP1 Improve Prognostic Stratification of Patients with Chronic Myelomonocytic Leukemia

Chiara Elena, MD, Anna Gallì, PhD, Esperanza Such, PhD, Ulrich Germing, Ettore Rizzo, PhD, Jose Cervera, MD, Elisabetta Molteni, PhD, Esther Schuler, Ilaria Ambaglio, MD, Maria Lopez-Pavia, Silvia Zibellini, PhD, Andrea Kuendgen, MD, Erica Travaglino, Reyes Sancho-Tello, Matteo G Della Porta, MD, Ana Isabel Vicente, Guillermo F. Sanz, MD PhD, Luca Malcovati, MD, Mario Cazzola, MD

Blood (2014) 124 (21): 1915.

https://doi.org/10.1182/blood.V124.21.1915.1915

Published: 2014

Journal Articles

MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance

Marzia Varettoni, Silvia Zibellini, Luca Arcaini, Emanuela Boveri, Sara Rattotti, Cristiana Pascutto, Silvia Mangiacavalli, Manuel Gotti, Lara Pochintesta, Marco Paulli, Mario Cazzola

Blood (2013) 122 (13): 2284–2285.

https://doi.org/10.1182/blood-2013-07-513366

Published: 2013

Journal Articles

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström’s macroglobulinemia and related lymphoid neoplasms

Marzia Varettoni, Luca Arcaini, Silvia Zibellini, Emanuela Boveri, Sara Rattotti, Roberta Riboni, Alessandro Corso, Ester Orlandi, Maurizio Bonfichi, Manuel Gotti, Cristiana Pascutto, Silvia Mangiacavalli, Giorgio Croci, Valeria Fiaccadori, Lucia Morello, Maria Luisa Guerrera, Marco Paulli, Mario Cazzola

Blood (2013) 121 (13): 2522–2528.

https://doi.org/10.1182/blood-2012-09-457101

Published: 2013

Journal Articles

Hierarchical Clustering of B-Cell Receptor Structures in Splenic Marginal Zone Lymphoma

Paolo Marcatili, Silvia Zibellini, Sara Rattotti, Anna Chailyan, Marzia Varettoni, Lucia Morello, Emanuela Boveri, Marco Lucioni, Maurizio Bonfichi, Manuel Gotti, Valeria Fiaccadori, Marco Paulli, Anna Tramontano, Luca Arcaini

Blood (2012) 120 (21): 1585.

https://doi.org/10.1182/blood.V120.21.1585.1585

Published: 2012

Journal Articles

Constant Activation of the RAF-MEK-ERK Pathway As a Diagnostic and Therapeutic Target in Hairy Cell Leukemia.

Enrico Tiacci, Gianluca Schiavoni, Maria Paola Martelli, Emanuela Boveri, Roberta Pacini, Alessia Tabarrini, Silvia Zibellini, Alessia Santi, Valentina Pettirossi, Elisabetta Fortini, Stefano Ascani, Luca Arcaini, Giorgio Inghirami, Marco Paulli, Brunangelo Falini

Blood (2012) 120 (21): 2657.

https://doi.org/10.1182/blood.V120.21.2657.2657

Published: 2012

NARROW

Persistence of Monotypic Plasma Cells after Chemoimmunotherapy in Patients with Waldenström Macroglobulinemia: A Matter of Time?

Prospective Evaluation of Minimal Residual Disease in Waldenström Macroglobulinemia across Different Tissues and Treatments: Results of the “BIO-WM” Trial of the Fondazione Italiana Linfomi (FIL)

Molecular Characterization of Diffuse Large B-Cell Lymphoma Associated to Hepatitis C Virus Infection

Relationship between clone metrics and clinical outcome in clonal cytopenia

Characterization of B-Cell and Plasma Cell Compartment By Eight-Color Multiparameter Flow Cytometry in Patients with Waldenstrom Macroglobulinemia Prospectively Enrolled in the Fondazione Italiana Linfomi (FIL) BIO-WM Trial

Targeted Next Generation Sequencing Reveals Molecular Heterogeneity in Non-CLL Clonal B-Cell Lymphocytosis

JAK inhibitors and risk of B-cell lymphomas

Prevalence of Clonal Hematopoiesis and Mutation Patterns in Unexplained Anemia of Community-Dwelling Elderly Individuals: A Case-Control Study

Lymphoplasmacytic Lymphoma Not Associated with an IgM Monoclonal Paraprotein Has Distinctive Clinical and Biological Features and a Similar Outcome As Compared with Waldenstrom's Macroglobulinemia: Multicentric Study of the Rete Ematologica Lombarda

Clinical significance of somatic mutation in unexplained blood cytopenia

Targeted Next Generation Sequencing Identifies Novel Genetic Mutations in Patients with Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma or IgM-Monoclonal Gammopathies of Undetermined Significance

Somatic Mutations Are Frequently Detected in Chronic Myeloid Leukemia in Chronic Phase and Do Not Affect Response to Tyrosine-Kinase Inhibitors

Driver Somatic Mutations and Transplantation Decision Making in Patients with Myelodysplastic Syndrome

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia

Efficacy and Toxicity of Nucleoside Analogs in Patients with Hairy Cell Leukemia Treated Outside Clinical Trials

Somatic Mutations of ASXL1 , RUNX1 and SETBP1 Improve Prognostic Stratification of Patients with Chronic Myelomonocytic Leukemia

MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström’s macroglobulinemia and related lymphoid neoplasms

Hierarchical Clustering of B-Cell Receptor Structures in Splenic Marginal Zone Lymphoma

Constant Activation of the RAF-MEK-ERK Pathway As a Diagnostic and Therapeutic Target in Hairy Cell Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only